002038.SZ
002038.SZ
CNE000001L31
SL PHARM
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 623.643.929 660.419.604
5.6%
Cost of Revenue 236.087.807 211.533.255
11.6%
Gross Profit 387.556.122 448.886.349
13.7%
390.206.084 405.116.990
3.7%
Operating Income -2.649.963 43.769.359
106.1%
Pretax Income -278.144.237 -133.749.653
108.0%
Net Income Common Stockholders -347.197.803 -74.065.658
368.8%
-- --
--
-- --
--
ende